National Academies Press: OpenBook
« Previous: References
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2011. Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13015.
×

Appendix A
Workshop Agenda

Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Drug Development


July 22, 2010


The Keck Center, Room 100

500 Fifth Street, N.W.

Washington, DC 20001

MEETING OBJECTIVE

To explore relevant issues related to developing a cultural, legal, and behavioral framework of collaboration that enables biospecimen and data sharing.

  • What are the critical factors necessary for a successful collaboration?

  • What lessons can be learned from existing collaborations?

  • What are the challenges that exist and potential ways to overcome them?

8:00-9:00 A.M.

WORKING BREAKFAST

9:00 A.M.

PUBLIC WORKSHOP BEGINS

9:00-9:10 A.M.

Welcome and Introductory Remarks

 

Geoffrey Ginsburg, Director, Center for Genomic Medicine, Institute for Genomic Sciences & Policy, Duke University

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2011. Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13015.
×

9:10-9:55 A.M.

EXTENDING THE SPECTRUM OF PRECOMPETITIVE ONCOLOGY BIOMEDICAL RESEARCH: A SUMMARY

 

Moderator: Martha Turner, American Nurses Association

9:10-9:35 A.M.

Lessons Learned

 

Stephen Friend, President and Chief Executive Officer (CEO), Sage Bionetworks

9:35-9:55 A.M.

Discussion

9:55-11:30 A.M.

REQUISITES FOR SUCCESSFUL PRECOMPETITIVE COLLABORATION

 

Moderator: Sharon Terry, Genetic Alliance

9:55-10:15 A.M.

The Architecture of Collaboration

 

William J. Spencer, Chairman Emeritus, SEMATECH

10:15-10:35 A.M.

Requisites from the Pharmaceutical Industry

 

Aidan Power, Vice President and Global Head of Molecular Medicine, Pfizer Inc.

10:35-10:50 A.M.

BREAK

10:50-11:10 A.M.

Requisites from Diagnostic Companies

 

Marcia Eisenberg, Senior Vice President, LabCorp

11:10-11:30 A.M.

Requisites from Academia

 

Neal Cohen, Vice Dean, School of Medicine, Professor of Anesthesia and Perioperative Care and Medicine, Director of International Medical Services, University of California, San Francisco

11:30 A.M.-12:30 P.M.

WORKING LUNCH

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2011. Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13015.
×

12:30-2:05 P.M.

FRAMEWORK OF COLLABORATIONS WITH THE PHARMACEUTICAL INDUSTRY

 

Moderator: Aidan Power, Pfizer Inc.

12:30-12:50 P.M.

Public–Private Partnerships with NIH or Government

 

Thomas Insel, Director of the National Institute of Mental Health, National Institutes of Health

12:50-1:10 P.M.

Advancing Technological Achievements Through Collaboration

 

Christopher Beecher, Research Professor, Michigan Center for Translational Pathology, University of Michigan

1:10-1:30 P.M.

Open Access Partnerships

 

Aled Edwards, Director and CEO, Structural Genomics Consortium; Professor, Department of Medical Biophysics, University of Toronto

1:30-1:50 P.M.

Access to Large-Scale Data Networks

 

Stephen Friend, President and CEO, Sage Bionetworks

1:50-2:05 P.M.

BREAK

2:05-4:05 P.M.

BIOSPECIMENS

 

Moderator: Geoffrey Ginsburg, Duke University

2:05-2:25 P.M.

Sustaining Access to Biospecimens

 

Martin Yuille, Reader in Biobanking, Co-director, Centre for Integrated Genomic Medical Research, University of Manchester

2:25-2:45 P.M.

Developing Common Biorepository Infrastructures

 

Carolyn Compton, Director, Office of Biorepositories and Biospecimen Research, National Cancer Institute

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2011. Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13015.
×

2:45-3:05 P.M.

Linking Health Outcomes Data to Biorepository Samples

 

Cynthia Helphingstine, President and CEO, Fairbanks Institute for Healthy Communities

3:05-3:25 P.M.

Creating a National Virtual Biospecimen Bank

 

Lorraine Q. Frazier, Nancy B. Willerson Distinguished Professorship, Assistant Dean & Department Chair, Nursing Systems, Professor, Department of Nursing Systems, University of Texas Health Science Center at Houston

3:25-3:45 P.M.

Opportunities and Challenges of Clinical and Genetic Data Access in the Pharmaceutical Industry

 

Sally John, Head of Human Genetics, Molecular Medicine, PharmaTherapeutics Research, Pfizer Inc.

3:45-4:05 P.M.

Ethical Challenges for Biospecimen and Data Sharing

 

Ellen Wright Clayton, Rosalind E. Franklin Professor of Genetics and Health Policy; Director, Center for Biomedical Ethics and Society, Vanderbilt University

4:05-5:05 P.M.

PANEL DISCUSSION

4:05 - 5:05 P.M.

Developing a cultural, legal, and behavioral framework of collaboration that enables resource sharing in order to accelerate genomics-based drug and diagnostic product development

 

Moderator: Stephen Eck, Eli Lilly and Company

 

Panelists:

 

Ellen Wright Clayton, Rosalind E. Franklin Professor of Genetics and Health Policy; Director, Center for Biomedical Ethics and Society, Vanderbilt University

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2011. Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13015.
×

 

Kelly Edwards, Associate Professor, Department of Bioethics and Humanities, University of Washington School of Medicine

Lorraine Q. Frazier, Nancy B. Willerson Distinguished Professorship, Assistant Dean & Department Chair, Nursing Systems, Professor, Department of Nursing Systems, University of Texas Health Science Center at Houston

Geoffrey Ginsburg, Director, Center for Genomic Medicine, Institute for Genomic Sciences & Policy, Duke University

Garry Neil, Corporate Vice President, COSAT, Johnson & Johnson

William J. Spencer, Chairman Emeritus, SEMATECH

Sharon Terry, President and CEO, Genetic Alliance

5:05-5:30 P.M.

SUMMARY AND CONCLUSIONS

 

Geoffrey Ginsburg, Director, Center for Genomic Medicine, Institute for Genomic Sciences & Policy, Duke University

Stephen Eck, Vice President, Translational Medicine & Pharmacogenomics, Eli Lilly and Company

Aidan Power, Vice President and Global Head of Molecular Medicine, Pfizer Inc.

Sharon Terry, President and CEO, Genetic Alliance

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2011. Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13015.
×

This page intentionally left blank.

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2011. Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13015.
×
Page 57
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2011. Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13015.
×
Page 58
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2011. Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13015.
×
Page 59
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2011. Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13015.
×
Page 60
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2011. Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13015.
×
Page 61
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2011. Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13015.
×
Page 62
Next: Appendix B: Speaker Biographical Sketches »
  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!